Active ingredientCarbimazoleCat. No. P-C038-001CAS 22232-54-8Family · Pharmaceutical analytical standards
Carbimazole
An antithyroid drug for hyperthyroidism: it is a prodrug that the body turns into methimazole, which blocks thyroid peroxidase and reduces thyroid hormone production. Described in 1951 by Alexander Lawson, C. Rimington and C. E. Searle, it is on the WHO Model List of Essential Medicines. This family brings together the active ingredient and labelled standards.
Did you know?It acts quickly on the thyroid, but blood hormone levels fall more slowly: the stores of hormone already made and kept in the gland must be used up first.
Go to the active ingredient →Active ingredientCarbimazoleCat. No. P-C038-001CAS 22232-54-8
Isotopically labelledCarbimazole-d5Cat. No. P-C038-002No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceCarbimazole CRSEDQM code C0465000Family CarbimazoleNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.